Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IRF3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
IRF3 is a gene implicated in neurodegeneration research. Key relationships include: activates, regulates, inhibits. Associated with AD, ALI, ALS. Connected to 292 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | IRF3 |
| Chromosome | 19q13.33 |
| Protein Type | Transcription Factor |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Primary Expression | most cell types, including: - Neurons and astrocytes in the brain - Microglia - Pe |
| Molecular Weight | 47 kDa |
| Amino Acids | 424 aa |
| Exons | 10 |
| Pathways | Akt, Autophagy, Innate Immunity, Nf-Κb, Pi3K |
| NCBI Gene ID | 7099 |
| GeneCards | IRF3 |
| Human Protein Atlas | IRF3 |
| Associated Diseases | AD, ALI, Als, Atherosclerosis, cancer |
| Interactions | Actin, AIM2, AKT, AKT1, ALS, ALZHEIMER |
| KG Connections | 459 knowledge graph edges |
| Databases | GeneCardsUniProtHPASTRING |
Knowledge base pages for this entity
graph TD
Virus["Viral RNA / cGAS-STING"] -->|"Activates"| TBK1["TBK1 Kinase"]
TBK1 -->|"Phosphorylates"| IRF3["IRF3 Transcription Factor"]
IRF3 -->|"Induces"| IFN["Type I Interferons"]
IRF3 -->|"Activates"| CCL5["CCL5 / RANTES"]
IRF3 -->|"Activates"| Apoptosis["Apoptosis"]
IRF3 -->|"Activates"| Autophagy["Autophagy"]
IRF3 -->|"Activates"| AKT1["AKT1 Survival"]
IRF3 -->|"Cross-talks"| EGFR["EGFR Pathway"]
IRF3 -->|"Regulates"| Chromatin["Chromatin Remodeling"]
IRF3 -.Neuroinflammation.-> AD["Alzheimer's Disease"]
IRF3 -.Dual role.-> Cancer["Cancer: Suppressor and Promoter"]| Target | Relation | Type | Str |
|---|---|---|---|
| CGAS | activates | gene | 1.00 |
| STING | activates | gene | 1.00 |
| CGAS-STING | activates | gene | 1.00 |
| DNA | activates | gene | 1.00 |
| Als | activates | disease | 0.95 |
| IFN | activates | protein | 0.94 |
| Type I Interferon Expression | activates | process | 0.90 |
| Inflammatory Phenotype | associated_with | phenotype | 0.90 |
| type I interferon | associated_with | protein | 0.90 |
| Infection | activates | disease | 0.85 |
| Tumor | activates | disease | 0.85 |
| Cancer | activates | disease | 0.85 |
| Immune Response | activates | pathway | 0.80 |
| Toll-Like Receptor | activates | pathway | 0.80 |
| TBK1 | activates | gene | 0.80 |
| GENES | activates | gene | 0.80 |
| Innate Immunity | activates | pathway | 0.80 |
| Fibrosis | activates | disease | 0.75 |
| Inflammation | inhibits | disease | 0.75 |
| Infection | implicated_in | disease | 0.75 |
| Inflammation | activates | disease | 0.75 |
| SMC | regulates | cell_type | 0.72 |
| CGAS | regulates | gene | 0.70 |
| Autophagy | regulates | pathway | 0.70 |
| CGAS-STING | regulates | gene | 0.70 |
| TBK1 | inhibits | gene | 0.70 |
| Nf-Κb | regulates | pathway | 0.70 |
| CGAS | inhibits | gene | 0.70 |
| ubiquitin-proteasome | participates_in | pathway | 0.70 |
| DNA | inhibits | gene | 0.70 |
| CGAS-STING | inhibits | gene | 0.70 |
| TNF-Α | inhibits | gene | 0.70 |
| NF-kB signaling | participates_in | pathway | 0.70 |
| Oxidative Stress | activates | pathway | 0.70 |
| MTDNA | inhibits | gene | 0.70 |
| Nf-Κb | activates | pathway | 0.70 |
| Invasion | activates | pathway | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| MTDNA | activates | gene | 0.70 |
| CANCER | activates | gene | 0.70 |
| Neurodegeneration | activates | disease | 0.65 |
| Infection | causes | disease | 0.65 |
| Glioblastoma | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Depression | activates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Depression | expressed_in | disease | 0.65 |
| Neuroinflammation | expressed_in | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| TBK1 | activates | gene | 1.00 |
| STING1 | activates | protein | 0.90 |
| ZBP1 | interacts_with | protein | 0.90 |
| TLR2 | inhibits | protein | 0.80 |
| INFLAMMATION | activates | gene | 0.80 |
| STING | activates | gene | 0.80 |
| AUTOPHAGY | regulates | gene | 0.70 |
| MAVS | activates | gene | 0.70 |
| RAS | activates | gene | 0.70 |
| INFLAMMATION | inhibits | gene | 0.70 |
| NF-ΚB | activates | gene | 0.70 |
| TNF | inhibits | gene | 0.70 |
| NF-ΚB | regulates | gene | 0.70 |
| YTHDF2 degradation | regulates | phenotype | 0.70 |
| MITOCHONDRIAL DNA | activates | gene | 0.70 |
| DSDNA | activates | gene | 0.70 |
| CYTOKINES | activates | gene | 0.70 |
| TBK1 | phosphorylates | protein | 0.64 |
| GADD45G | regulates | gene | 0.60 |
| P62 | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| TFAM | activates | gene | 0.60 |
| UBIQUITIN | activates | gene | 0.60 |
| UBIQUITIN | regulates | gene | 0.60 |
| TAX1BP1 | regulates | gene | 0.60 |
| P62 | regulates | gene | 0.60 |
| NBR1 | regulates | gene | 0.60 |
| TBK1 | regulates | gene | 0.60 |
| OPTN | regulates | gene | 0.60 |
| NDP52 | regulates | gene | 0.60 |
| STING | regulates | gene | 0.60 |
| TRAF6 | activates | gene | 0.60 |
| JNK | activates | gene | 0.60 |
| AKT1 | activates | gene | 0.60 |
| EGF | activates | gene | 0.60 |
| TBK1 | interacts_with | gene | 0.60 |
| TLR3 | activates | gene | 0.60 |
| TLR4 | activates | gene | 0.60 |
| MLKL | activates | gene | 0.60 |
| RIPK1 | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| PER | activates | gene | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| DEPRESSION | expressed_in | gene | 0.60 |
| ALS | activates | gene | 0.60 |
| SQSTM1 | activates | gene | 0.60 |
| MAP3K4 | regulates | gene | 0.60 |
| NEURODEGENERATION | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.910
neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.888
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.89 · 2026-04-06
closed · Rounds: 4 · Score: 0.95 · 2026-04-01
Hypotheses and analyses mentioning IRF3 in their description or question text
No additional research found